STOCK TITAN

Intercure Ltd. Stock Price, News & Analysis

INCR NASDAQ

Company Description

Overview of Intercure Ltd

Intercure Ltd (INCR) is a comprehensive cannabis and biomed company that engages in the research, cultivation, production, and distribution of GMP-certified, pharmaceutical-grade medical cannabis products. With a deep commitment toward excellence, the company employs a vertically integrated, "seed-to-sale" model, ensuring rigorous quality controls and product consistency from cultivation to final distribution. Its operations are underpinned by a focus on advanced research and adherence to internationally recognized manufacturing standards, which positions the company at a critical juncture in the expanding global medical cannabis industry.

Business Segments and Core Operations

Intercure’s operations are organized across two primary business segments:

  • Cannabis Segment: This is the primary revenue-generating arm of the company. It focuses on the production of high-quality medical cannabis products designed for use in hospitals, pharmacies, research institutions, and by government bodies. Leveraging a vertically integrated framework, the company maintains complete oversight of its production processes, ensuring superior product quality and adherence to strict regulatory standards.
  • Biomed Segment: Complementing the cannabis operations, the Biomed segment emphasizes research and development within the realm of therapeutic cannabis applications. This segment supports innovation and contributes to the continuous improvement of product offerings by integrating scientific research with state-of-the-art production practices.

Global Positioning and Competitive Landscape

Intercure distinguishes itself in the competitive cannabis industry by being one of the fastest growing entities outside of North America. The company’s market standing is reinforced by its best-in-class international partnerships and a well-established distribution network that spans multiple regions. Its wholly owned subsidiary, Canndoc, is recognized as one of the largest licensed cannabis producers in Israel, and it was among the first to meet Good Manufacturing Practices (GMP) certification for medical cannabis products. This unique positioning enables Intercure to cater to an expanding international market, supplying pharmaceutical-grade products across diverse regulatory environments.

Operational Excellence and Vertical Integration

The hallmark of Intercure’s operational strategy is its high-margin, vertically integrated model. By streamlining processes from seed to final sale, the company not only ensures consistent quality but also maximizes operational efficiency. Strategic use of advanced cultivation techniques, rigorous quality control measures, and adherence to pharmaceutical-grade production protocols form the backbone of its operational excellence. This methodical approach helps maintain a stable and reliable supply chain, enabling the company to meet both current and emerging market demands.

International Partnerships and Distribution Network

The company has carefully built a market-leading distribution network that plays a pivotal role in its global success. By forging strong international partnerships, Intercure extends its reach far beyond local markets, catering to a diverse range of medical and research facilities worldwide. This expansive network is critical in fostering long-term relationships with healthcare institutions and regulatory bodies, thereby ensuring consistent demand for its products across various regions.

Quality Assurance and Standards

At the core of Intercure’s manufacturing process is an unwavering commitment to quality. The company’s production facilities are designed to meet or exceed GMP standards, ensuring that every product is manufactured with the utmost attention to quality and safety. This dedication to maintaining high quality not only satisfies stringent regulatory requirements but also establishes a strong trust base with healthcare providers, patients, and other stakeholders in the medicinal cannabis industry.

Research, Development, and Industry Expertise

Intercure’s emphasis on research and development demonstrates a robust commitment to innovation within the medical cannabis space. By integrating advanced research initiatives into its production framework, the company ensures that its products remain at the forefront of pharmaceutical applications. The synergy between its research and operational insights solidifies its position as an informed and reliable provider in the global market. This focus on continuous improvement helps the company stay responsive to evolving industry standards and scientific advancements, thereby retaining a competitive edge.

Market Differentiation and Expertise

What sets Intercure apart is its unique combination of vertical integration, stringent quality assurance, and expansive international partnerships. These elements collectively form a robust business model that not only drives operational success but also positions the company as a knowledgeable authority in the cannabis industry. Investors and industry analysts can appreciate this comprehensive approach, which is characterized by transparent operational practices, adherence to high safety and quality standards, and a commitment to meeting international regulatory requirements.

Strategic Significance in the Global Cannabis Market

In an industry marked by rapid change and increasing demand for medicinal cannabis, Intercure Ltd has successfully positioned itself as a dependable source of high-quality, pharmaceutical-grade products. The company’s operations emphasize sustainability, rigorous quality control, and strategic market placement which together enable it to effectively navigate diverse regulatory landscapes. By serving a range of vital sectors including medical, research, and governmental institutions, Intercure reinforces its relevance and stability in an increasingly competitive global market.

Conclusion

Intercure Ltd stands as a paradigm of operational excellence in the medical cannabis industry. Its integrated approach—from research and cultivation to production and distribution—ensures a high level of quality, enabling it to meet the demanding requirements of global standards. With an expansive distribution network, internationally certified production processes, and a well-articulated dual-segment strategy, Intercure exemplifies how expertise, robust operational frameworks, and strategic partnerships can coalesce to foster sustained industry success.

Stock Performance

$—
0.00%
0.00
Last updated:
-50.4 %
Performance 1 year
$80.7M
Market Cap
54.5M
Shares outstanding

SEC Filings

No SEC filings available for Intercure Ltd..

Financial Highlights

$2,672,064,000
Revenue (TTM)
-$138,469,000
Net Income (TTM)
-$1.85
Diluted EPS (TTM)
$198,258,000
Operating Cash Flow
-5.18%
Net Profit Margin
-1.08%
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Intercure Ltd. (INCR)?

The current stock price of Intercure Ltd. (INCR) is $1.5 as of June 18, 2025.

What is the market cap of Intercure Ltd. (INCR)?

The market cap of Intercure Ltd. (INCR) is approximately 80.7M.

What is the revenue (TTM) of Intercure Ltd. (INCR) stock?

The trailing twelve months (TTM) revenue of Intercure Ltd. (INCR) is $2,672,064,000.

What is the net income of Intercure Ltd. (INCR)?

The trailing twelve months (TTM) net income of Intercure Ltd. (INCR) is -$138,469,000.

What is the earnings per share (EPS) of Intercure Ltd. (INCR)?

The diluted earnings per share (EPS) of Intercure Ltd. (INCR) is -$1.85 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Intercure Ltd. (INCR)?

The operating cash flow of Intercure Ltd. (INCR) is $198,258,000.

What is the profit margin of Intercure Ltd. (INCR)?

The net profit margin of Intercure Ltd. (INCR) is -5.18%.

What is the operating margin of Intercure Ltd. (INCR)?

The operating profit margin of Intercure Ltd. (INCR) is -1.08%.

What is the gross margin of Intercure Ltd. (INCR)?

The gross profit margin of Intercure Ltd. (INCR) is 53.89%.

What is the current ratio of Intercure Ltd. (INCR)?

The current ratio of Intercure Ltd. (INCR) is 1.23, indicating the company's ability to pay short-term obligations.

What is the gross profit of Intercure Ltd. (INCR)?

The gross profit of Intercure Ltd. (INCR) is $1,440,041,000 on a trailing twelve months (TTM) basis.

What is the operating income of Intercure Ltd. (INCR)?

The operating income of Intercure Ltd. (INCR) is -$28,866,000.

What is Intercure Ltd's core business?

Intercure Ltd is focused on the research, cultivation, production, and distribution of pharmaceutical-grade cannabis products using a vertically integrated system.

How does the company generate revenue?

The primary revenue is generated through the Cannabis segment, which supplies GMP-certified medical cannabis to hospitals, pharmacies, research facilities, and government organizations.

What distinguishes Canndoc in the cannabis industry?

Canndoc, a wholly owned subsidiary of Intercure, is renowned for its adherence to Good Manufacturing Practices (GMP) and delivering pharmaceutical-grade medical cannabis products that meet rigorous quality standards.

What are the key segments of Intercure Ltd?

The company operates through two main segments: the Cannabis segment, focused on production and market distribution, and the Biomed segment, which emphasizes research and product development.

How does Intercure maintain product quality?

The company enforces strict quality control measures, following GMP guidelines and maintaining a fully integrated production process from cultivation to distribution to ensure consistent product excellence.

What is unique about Intercure's distribution network?

Intercure benefits from a market-leading distribution network built on robust international partnerships, which expands its reach across multiple global regions.

How does Intercure differentiate itself from competitors?

Its combination of a vertically integrated operational model, pharmaceutical-grade product standards, and strategic global partnerships sets Intercure apart, enabling it to effectively meet diverse market needs.

Which industries and customers does Intercure serve?

Intercure supplies high-quality cannabis products to a wide range of sectors including healthcare, research institutions, governmental bodies, and pharmacies, ensuring broad market applicability.